Globus Medical (GMED) Set to Announce Quarterly Earnings on Monday
Globus Medical (NYSE:GMED) is set to announce its earnings results after the market closes on Monday, February 26th. Analysts expect the company to announce earnings of $0.34 per share for the quarter.
Globus Medical (NYSE GMED) opened at $48.22 on Monday. Globus Medical has a 52-week low of $26.95 and a 52-week high of $48.40. The firm has a market capitalization of $4,647.25, a P/E ratio of 43.84, a P/E/G ratio of 2.82 and a beta of 0.48.
A number of research analysts have commented on the company. Barclays restated a “sell” rating and set a $36.00 price target on shares of Globus Medical in a research note on Wednesday, January 10th. Needham & Company LLC restated a “hold” rating on shares of Globus Medical in a research note on Thursday, November 9th. Zacks Investment Research upgraded Globus Medical from a “sell” rating to a “hold” rating in a research note on Friday, November 10th. ValuEngine upgraded Globus Medical from a “hold” rating to a “buy” rating in a research note on Friday, November 10th. Finally, BTIG Research restated a “buy” rating and set a $37.00 price target on shares of Globus Medical in a research note on Thursday, November 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and nine have assigned a buy rating to the company’s stock. Globus Medical presently has an average rating of “Buy” and an average price target of $40.57.
TRADEMARK VIOLATION NOTICE: “Globus Medical (GMED) Set to Announce Quarterly Earnings on Monday” was originally published by Watch List News and is owned by of Watch List News. If you are accessing this story on another website, it was illegally copied and republished in violation of United States and international copyright laws. The correct version of this story can be viewed at https://www.watchlistnews.com/globus-medical-gmed-set-to-announce-quarterly-earnings-on-monday/1875277.html.
Globus Medical Company Profile
Globus Medical, Inc (Globus) is a medical device company focused on the design, development and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. The Company is focused on implants that promote healing in patients with spine disorders. The Company’s products fall into one of two categories: Innovative Fusion or Disruptive Technologies.
Receive News & Ratings for Globus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globus Medical and related companies with MarketBeat.com's FREE daily email newsletter.